MedTrace Logo

Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress.

NCT04780763 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2022-03-23

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of Lactobacillus rhamnosus CNCM I-3690 consumption on subjective anxiety levels in healthy subjects undergoing academic stress.

Conditions

  • Anxious Healthy Subjects

Interventions

OTHER

Milk product fermented by lactic bacteria or not fermented

2 bottles of 100g consumed daily during 28 days

Sponsors & Collaborators

  • Danone Global Research & Innovation Center

    lead INDUSTRY

Principal Investigators

  • Rim HASSOUNA, PhD · DANONE RESEARCH, PALAISEAU, FRANCE

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-04
Primary Completion
2021-09-14
Completion
2021-12-22

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04780763 on ClinicalTrials.gov